Clinical Trials Logo

Clinical Trial Summary

PGS has been the most effective method for embryo selection in IVF cycles. Euploidy rates decrease significantly with advancing maternal age (AMA). The dosage of gonadotropins also may be increased to recruit an adequate number of follicles in AMA women, minimal Stimulation Protocol (MSP) with the new combination of human menopausal gonadotrophin (hMG) and clomiphene citrate (CC) for controlled ovarian hyperstimulation is defined for poor ovarian response women. The aim of this study is to show minimal stimulation protocol affect euploidy and pregnancy rates in preimplatation genetic screening (PGS) cycles with single embryo transfer.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Preimplantation Genetic Screening

NCT number NCT05220995
Study type Observational
Source Nigde Omer Halisdemir University
Contact
Status Recruiting
Phase
Start date May 15, 2021
Completion date January 25, 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04621773 - Live Birth Rate in Patients With Unexplained Recurrent Pregnancy Loss
Recruiting NCT03976544 - Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients Phase 4
Terminated NCT03173885 - Investigating the Cryopreserved Blastocyst's ImplantatiOn Potential After Genetic Screening N/A
Completed NCT03001648 - Cumulative Live Birth Rates in Patients With Repeated Implantation Failure (RIF) Undergoing Preimplantation Genetic Screening (PGS ) N/A
Completed NCT03062969 - The Transition From Blastomere to Trophectoderm Biopsy: Comparing Two PGS Strategies N/A